Patients with advanced bladder cancer with alterations in the FGFR3 gene respond well to investigational drug, TYRA-300 (IMAGE)

European Organisation for Research and Treatment of Cancer

Patients with advanced bladder cancer with alterations in the FGFR3 gene respond well to investigational drug, TYRA-300

Caption

Associate Professor, Ben Tran, a medical oncologist at Peter McCallum Cancer Centre in Melbourne, Australia

Credit

Ben Tran

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.